7Baggers
 turnstone biologics corp (tsbx) institutional confidence  TradingKey Thu, 18 Jun 2026 03:26:13 GMT
 turnstone biologics corp. - common stock (nasdaq:tsbx) stock quote  The Chronicle-Journal Mon, 18 May 2026 23:22:17 GMT
 tradingkey  TradingKey Tue, 12 May 2026 15:15:17 GMT
 turnstone biologics to be acquired by xoma royalty  MSN Sun, 26 Apr 2026 04:54:01 GMT
 turnstone biologics to be acquired by xoma royalty  MSN Sat, 25 Apr 2026 09:11:14 GMT
 turnstone biologics to be acquired by xoma royalty  MSN Fri, 24 Apr 2026 21:12:45 GMT
 turnstone biologics to be acquired by xoma royalty  MSN Thu, 23 Apr 2026 13:43:35 GMT
 turnstone biologics to be acquired by xoma royalty  MSN Tue, 21 Apr 2026 18:01:15 GMT
 turnstone biologics to be acquired by xoma royalty  MSN Tue, 14 Apr 2026 09:33:21 GMT
 sectors review: what is turnstone biologics corps market position  baoquankhu1.vn Fri, 10 Apr 2026 19:18:23 GMT
 hillevax to be acquired by xoma royalty  MSN Mon, 09 Feb 2026 13:06:11 GMT
 clinical-stage i-o company calls up b-ms vp  The Pharma Letter Thu, 08 Jan 2026 09:20:05 GMT
 turnstone biologics to be acquired by xoma royalty  MSN Sun, 04 Jan 2026 20:25:35 GMT
 published on: 2025-11-19 11:19:31  newser.com Wed, 19 Nov 2025 17:19:31 GMT
 landbridge company reports strong q3 2025 growth  The Globe and Mail Fri, 14 Nov 2025 08:00:00 GMT
 xoma royalty reports third quarter and year to date 2025  GlobeNewswire Wed, 12 Nov 2025 08:00:00 GMT
 published on: 2025-11-06 09:52:25  newser.com Thu, 06 Nov 2025 15:52:25 GMT
 published on: 2025-11-06 02:11:26  newser.com Thu, 06 Nov 2025 08:11:26 GMT
 published on: 2025-11-04 04:15:44  newser.com Tue, 04 Nov 2025 10:15:44 GMT
 published on: 2025-11-03 08:51:54  newser.com Mon, 03 Nov 2025 14:51:54 GMT
 published on: 2025-11-02 20:50:26  newser.com Mon, 03 Nov 2025 01:50:26 GMT
 published on: 2025-11-02 05:19:27  newser.com Sun, 02 Nov 2025 10:19:27 GMT

Turnstone Biologics Corp.
(NASDAQ:TSBX) 

TSBX stock logo

Turnstone Biologics is a clinical-stage biotechnology company developing new medicines to treat and cure solid tumors by pioneering a differentiated approach to TIL therapy.

Founded: 2014
IPO Price: $12 (Jul 21, 2023)
Sector: TECHNOLOGY
Industry: GENERAL

Share this website to your friends